FDA — authorised 1 April 1985
- Application: NDA050590
- Marketing authorisation holder: GLAXOSMITHKLINE
- Local brand name: TIMENTIN
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Timentin in United States
FDA authorised Timentin on 1 April 1985
Marketing authorisations
FDA — authorised 19 December 1986
- Application: ANDA062691
- Marketing authorisation holder: GLAXOSMITHKLINE
- Local brand name: TIMENTIN
- Indication: INJECTABLE — INJECTION
- Status: approved
Other Other approved in United States
Frequently asked questions
Is Timentin approved in United States?
Yes. FDA authorised it on 1 April 1985; FDA authorised it on 19 December 1986.
Who is the marketing authorisation holder for Timentin in United States?
GLAXOSMITHKLINE holds the US marketing authorisation.